recent articles

CAMBRIDGE, Mass., July 14, 2022 /PRNewswire/ -- VistaPath, the leading provider of artificial intelligence (AI)-based, data-driven pathology processing platforms, today announced that VistaPath Sentinel was validated in a clinical setting...

CAMBRIDGE, Mass., June 30, 2022 /PRNewswire/ -- VistaPath, the leading provider of artificial intelligence (AI)-based, data-driven pathology processing platforms, today announced that it has secured $4 million in seed funding led by...

The world’s first Artificial Intelligence (AI) software that can accurately perform breast cancer diagnosis has received approval for implementation in the UK and EU. The breast cancer diagnosis technology – called PANProfiler – has been...

In the latest round of AI funding, Israeli startup, Nucleai raised $5 million in seed round led by Vertex Ventures Israel and Grove Ventures Capital (GP) Ltd. Nucleai, a Tel Aviv-based startup, is developing an AI pathology system to help...

OR

platinum partners

gold partners

Silver Partners

Media Partners